Diagnostic validity of colchicine in patients with Familial Mediterranean fever View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-04-17

AUTHORS

Fatih Ozaltin, Yelda Bilginer, Bora Gülhan, Inci Bajin, Ozlem Erdogan, Mutlu Hayran, Engin Yılmaz, Seza Ozen

ABSTRACT

Although response to colchicine has been proposed as one of the diagnostic criteria in patients with Familial Mediterranean fever (FMF), the validity of this response has not been validated. The aim of this study was to assess the efficacy of the response to colchicine and to evaluate the extent of the effect of placebo. A double-blind randomized placebo-controlled trial with a cross-over design was conducted. The frequency of FMF attacks, the disease score, physical examination, and acute phase reactants were assessed at 0, 3, and 6 months. Blood samples were collected for complete blood count (CBC), erythrocyte sedimentation rate (ESR), levels of serum C-reactive protein (CRP) and serum amyloid A (SAA), and MEFV mutation analysis in 79 patients with a preliminary diagnosis of FMF. Patients were randomly allocated to receive either drug A or drug B in a double-blind fashion. The designated drug was switched at 3 months. Patients taking colchicine had less frequent FMF attacks (median 0) and lower FMF disease score (median 0) when compared to those on placebo (median 1 and 3, respectively) (p = 0.002 and p = 0.007, respectively). In genetically confirmed FMF patients, median attack number and median disease score was 0 under colchicine treatment, whereas these parameters were significantly higher in the placebo group (median 2 and 8, respectively) (p = 0.007 and p = 0.02, respectively) suggesting that colchicine is more effective than placebo in reducing attacks and disease score. Positive and negative predictive values were 70.2 and 37.5 %, respectively. During the placebo period, patients had less FMF attacks when compared to that of the pre-study period (median 2 vs 6, respectively) (p < 0.001). The high false positive rate raises concerns for considering the colchicine response test as diagnostic for FMF. The role of placebo on the attacks of periodic fever syndromes needs to be further investigated. More... »

PAGES

969-974

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10067-014-2598-y

DOI

http://dx.doi.org/10.1007/s10067-014-2598-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1036607097

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24740462


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Sedimentation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "C-Reactive Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child, Preschool", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colchicine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cross-Over Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytoskeletal Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA Mutational Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Familial Mediterranean Fever", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reproducibility of Results", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sensitivity and Specificity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Serum Amyloid A Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tubulin Modulators", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Departments of Pediatric Nephrology and Rheumatology, Hacettepe University Faculty of Medicine, 06100, Ankara, Sihhiye, Turkey", 
          "id": "http://www.grid.ac/institutes/grid.14442.37", 
          "name": [
            "Departments of Pediatric Nephrology and Rheumatology, Hacettepe University Faculty of Medicine, 06100, Ankara, Sihhiye, Turkey"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ozaltin", 
        "givenName": "Fatih", 
        "id": "sg:person.01146512213.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01146512213.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Pediatric Nephrology and Rheumatology, Hacettepe University Faculty of Medicine, 06100, Ankara, Sihhiye, Turkey", 
          "id": "http://www.grid.ac/institutes/grid.14442.37", 
          "name": [
            "Departments of Pediatric Nephrology and Rheumatology, Hacettepe University Faculty of Medicine, 06100, Ankara, Sihhiye, Turkey"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bilginer", 
        "givenName": "Yelda", 
        "id": "sg:person.01010215417.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010215417.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Pediatric Nephrology and Rheumatology, Hacettepe University Faculty of Medicine, 06100, Ankara, Sihhiye, Turkey", 
          "id": "http://www.grid.ac/institutes/grid.14442.37", 
          "name": [
            "Departments of Pediatric Nephrology and Rheumatology, Hacettepe University Faculty of Medicine, 06100, Ankara, Sihhiye, Turkey"
          ], 
          "type": "Organization"
        }, 
        "familyName": "G\u00fclhan", 
        "givenName": "Bora", 
        "id": "sg:person.01011617323.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01011617323.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Pediatric Nephrology and Rheumatology, Hacettepe University Faculty of Medicine, 06100, Ankara, Sihhiye, Turkey", 
          "id": "http://www.grid.ac/institutes/grid.14442.37", 
          "name": [
            "Departments of Pediatric Nephrology and Rheumatology, Hacettepe University Faculty of Medicine, 06100, Ankara, Sihhiye, Turkey"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bajin", 
        "givenName": "Inci", 
        "id": "sg:person.0755162262.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755162262.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sami Ulus Children\u2019s Hospital, Ankara, Turkey", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Sami Ulus Children\u2019s Hospital, Ankara, Turkey"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Erdogan", 
        "givenName": "Ozlem", 
        "id": "sg:person.0741617600.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741617600.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Preventive Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey", 
          "id": "http://www.grid.ac/institutes/grid.14442.37", 
          "name": [
            "Department of Preventive Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hayran", 
        "givenName": "Mutlu", 
        "id": "sg:person.0712577637.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0712577637.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Biology, Hacettepe University Faculty of Medicine, Ankara, Turkey", 
          "id": "http://www.grid.ac/institutes/grid.14442.37", 
          "name": [
            "Department of Medical Biology, Hacettepe University Faculty of Medicine, Ankara, Turkey"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Y\u0131lmaz", 
        "givenName": "Engin", 
        "id": "sg:person.01237130624.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01237130624.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Pediatric Nephrology and Rheumatology, Hacettepe University Faculty of Medicine, 06100, Ankara, Sihhiye, Turkey", 
          "id": "http://www.grid.ac/institutes/grid.14442.37", 
          "name": [
            "Departments of Pediatric Nephrology and Rheumatology, Hacettepe University Faculty of Medicine, 06100, Ankara, Sihhiye, Turkey"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ozen", 
        "givenName": "Seza", 
        "id": "sg:person.01141766457.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01141766457.76"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nrrheum.2010.181", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011009840", 
          "https://doi.org/10.1038/nrrheum.2010.181"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.ejhg.5200446", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052810936", 
          "https://doi.org/10.1038/sj.ejhg.5200446"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri3261", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029201311", 
          "https://doi.org/10.1038/nri3261"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.ejhg.5200674", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001982403", 
          "https://doi.org/10.1038/sj.ejhg.5200674"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-04-17", 
    "datePublishedReg": "2014-04-17", 
    "description": "Although response to colchicine has been proposed as one of the diagnostic criteria in patients with Familial Mediterranean fever (FMF), the validity of this response has not been validated. The aim of this study was to assess the efficacy of the response to colchicine and to evaluate the extent of the effect of placebo. A double-blind randomized placebo-controlled trial with a cross-over design was conducted. The frequency of FMF attacks, the disease score, physical examination, and acute phase reactants were assessed at 0, 3, and 6\u00a0months. Blood samples were collected for complete blood count (CBC), erythrocyte sedimentation rate (ESR), levels of serum C-reactive protein (CRP) and serum amyloid A (SAA), and MEFV mutation analysis in 79 patients with a preliminary diagnosis of FMF. Patients were randomly allocated to receive either drug A or drug B in a double-blind fashion. The designated drug was switched at 3\u00a0months. Patients taking colchicine had less frequent FMF attacks (median 0) and lower FMF disease score (median 0) when compared to those on placebo (median 1 and 3, respectively) (p\u2009=\u20090.002 and p\u2009=\u20090.007, respectively). In genetically confirmed FMF patients, median attack number and median disease score was 0 under colchicine treatment, whereas these parameters were significantly higher in the placebo group (median 2 and 8, respectively) (p\u2009=\u20090.007 and p\u2009=\u20090.02, respectively) suggesting that colchicine is more effective than placebo in reducing attacks and disease score. Positive and negative predictive values were 70.2 and 37.5\u00a0%, respectively. During the placebo period, patients had less FMF attacks when compared to that of the pre-study period (median 2 vs 6, respectively) (p\u2009<\u20090.001). The high false positive rate raises concerns for considering the colchicine response test as diagnostic for FMF. The role of placebo on the attacks of periodic fever syndromes needs to be further investigated.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10067-014-2598-y", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1093299", 
        "issn": [
          "0770-3198", 
          "1434-9949"
        ], 
        "name": "Clinical Rheumatology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "33"
      }
    ], 
    "keywords": [
      "familial Mediterranean fever", 
      "erythrocyte sedimentation rate", 
      "C-reactive protein", 
      "complete blood count", 
      "serum amyloid A", 
      "FMF attacks", 
      "disease score", 
      "Mediterranean fever", 
      "double-blind randomized placebo-controlled trial", 
      "randomized placebo-controlled trial", 
      "serum C-reactive protein", 
      "MEFV mutation analysis", 
      "placebo-controlled trial", 
      "double-blind fashion", 
      "acute phase reactants", 
      "effects of placebo", 
      "pre-study period", 
      "periodic fever syndrome", 
      "negative predictive value", 
      "role of placebo", 
      "cross-over design", 
      "placebo group", 
      "placebo period", 
      "physical examination", 
      "blood count", 
      "FMF patients", 
      "amyloid A", 
      "fever syndrome", 
      "phase reactants", 
      "blood samples", 
      "diagnostic criteria", 
      "placebo", 
      "patients", 
      "predictive value", 
      "diagnostic validity", 
      "preliminary diagnosis", 
      "drug B", 
      "high false positive rate", 
      "drug A", 
      "fever", 
      "scores", 
      "attack number", 
      "colchicine", 
      "mutation analysis", 
      "months", 
      "sedimentation rate", 
      "colchicine treatment", 
      "positive rate", 
      "false positive rate", 
      "response", 
      "syndrome", 
      "diagnosis", 
      "trials", 
      "drugs", 
      "efficacy", 
      "period", 
      "treatment", 
      "response test", 
      "examination", 
      "count", 
      "rate", 
      "group", 
      "aim", 
      "levels", 
      "criteria", 
      "protein", 
      "study", 
      "role", 
      "test", 
      "validity", 
      "effect", 
      "attacks", 
      "fashion", 
      "frequency", 
      "extent", 
      "concern", 
      "samples", 
      "number", 
      "analysis", 
      "values", 
      "parameters", 
      "design", 
      "reactants"
    ], 
    "name": "Diagnostic validity of colchicine in patients with Familial Mediterranean fever", 
    "pagination": "969-974", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1036607097"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10067-014-2598-y"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24740462"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10067-014-2598-y", 
      "https://app.dimensions.ai/details/publication/pub.1036607097"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_628.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10067-014-2598-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10067-014-2598-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10067-014-2598-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10067-014-2598-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10067-014-2598-y'


 

This table displays all metadata directly associated to this object as RDF triples.

292 TRIPLES      21 PREDICATES      131 URIs      119 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10067-014-2598-y schema:about N09fe4aecc61c4ba0ac87604dda8df794
2 N1432fcbd3c93411d9c1513541e427be6
3 N2452b5f62241486888aa16730c61a00f
4 N30bb77e5cd344dbeb7ba5422fa93c1e1
5 N36bfa23cf31b4e1db1f2ab77a916fc1c
6 N47a9bc1a70c34659bbc1af2a2ad85673
7 N6c6c194abd8d4f45a8a330edfd21d08e
8 N6f6cde9f3bb64ca592a79f938869b6b6
9 N773956a9465048328d3debcc5aa2f57b
10 N7ae58cc4217e41c396649193d8502eb8
11 N9df8fb72643d47f5aedc6eff7f7b3e17
12 Nb200df1b232445aeb06a63e2f33c0f77
13 Nb92c5fcf342148d982424ab4674f9214
14 Nbdaf50792c174fa6bcac61c6d26666b0
15 Nda0bf2fa30684273bfc426b4e44aacbe
16 Ne095f855103d4a629424ef220c0a4ac0
17 Nf4185d1bf1b14348ac1c51155286d1b8
18 Nf9e0f4d9e8b84ea19fab2d36a08c1b9b
19 Nfca43a4e39334102a750ff50faf71761
20 anzsrc-for:11
21 anzsrc-for:1102
22 schema:author Nef100bebac6d4af79dbfc0bb35ea4726
23 schema:citation sg:pub.10.1038/nri3261
24 sg:pub.10.1038/nrrheum.2010.181
25 sg:pub.10.1038/sj.ejhg.5200446
26 sg:pub.10.1038/sj.ejhg.5200674
27 schema:datePublished 2014-04-17
28 schema:datePublishedReg 2014-04-17
29 schema:description Although response to colchicine has been proposed as one of the diagnostic criteria in patients with Familial Mediterranean fever (FMF), the validity of this response has not been validated. The aim of this study was to assess the efficacy of the response to colchicine and to evaluate the extent of the effect of placebo. A double-blind randomized placebo-controlled trial with a cross-over design was conducted. The frequency of FMF attacks, the disease score, physical examination, and acute phase reactants were assessed at 0, 3, and 6 months. Blood samples were collected for complete blood count (CBC), erythrocyte sedimentation rate (ESR), levels of serum C-reactive protein (CRP) and serum amyloid A (SAA), and MEFV mutation analysis in 79 patients with a preliminary diagnosis of FMF. Patients were randomly allocated to receive either drug A or drug B in a double-blind fashion. The designated drug was switched at 3 months. Patients taking colchicine had less frequent FMF attacks (median 0) and lower FMF disease score (median 0) when compared to those on placebo (median 1 and 3, respectively) (p = 0.002 and p = 0.007, respectively). In genetically confirmed FMF patients, median attack number and median disease score was 0 under colchicine treatment, whereas these parameters were significantly higher in the placebo group (median 2 and 8, respectively) (p = 0.007 and p = 0.02, respectively) suggesting that colchicine is more effective than placebo in reducing attacks and disease score. Positive and negative predictive values were 70.2 and 37.5 %, respectively. During the placebo period, patients had less FMF attacks when compared to that of the pre-study period (median 2 vs 6, respectively) (p < 0.001). The high false positive rate raises concerns for considering the colchicine response test as diagnostic for FMF. The role of placebo on the attacks of periodic fever syndromes needs to be further investigated.
30 schema:genre article
31 schema:isAccessibleForFree false
32 schema:isPartOf N44835f4928464b798c632038ab57a4be
33 N611cc40f86f449a393234934468d0385
34 sg:journal.1093299
35 schema:keywords C-reactive protein
36 FMF attacks
37 FMF patients
38 MEFV mutation analysis
39 Mediterranean fever
40 acute phase reactants
41 aim
42 amyloid A
43 analysis
44 attack number
45 attacks
46 blood count
47 blood samples
48 colchicine
49 colchicine treatment
50 complete blood count
51 concern
52 count
53 criteria
54 cross-over design
55 design
56 diagnosis
57 diagnostic criteria
58 diagnostic validity
59 disease score
60 double-blind fashion
61 double-blind randomized placebo-controlled trial
62 drug A
63 drug B
64 drugs
65 effect
66 effects of placebo
67 efficacy
68 erythrocyte sedimentation rate
69 examination
70 extent
71 false positive rate
72 familial Mediterranean fever
73 fashion
74 fever
75 fever syndrome
76 frequency
77 group
78 high false positive rate
79 levels
80 months
81 mutation analysis
82 negative predictive value
83 number
84 parameters
85 patients
86 period
87 periodic fever syndrome
88 phase reactants
89 physical examination
90 placebo
91 placebo group
92 placebo period
93 placebo-controlled trial
94 positive rate
95 pre-study period
96 predictive value
97 preliminary diagnosis
98 protein
99 randomized placebo-controlled trial
100 rate
101 reactants
102 response
103 response test
104 role
105 role of placebo
106 samples
107 scores
108 sedimentation rate
109 serum C-reactive protein
110 serum amyloid A
111 study
112 syndrome
113 test
114 treatment
115 trials
116 validity
117 values
118 schema:name Diagnostic validity of colchicine in patients with Familial Mediterranean fever
119 schema:pagination 969-974
120 schema:productId N1f38f75138934d6987bf65423700f94c
121 Nacd014ec9f7c47318e4018344d249425
122 Nc13db71f067b45adb1d616e39b4ad47d
123 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036607097
124 https://doi.org/10.1007/s10067-014-2598-y
125 schema:sdDatePublished 2022-12-01T06:32
126 schema:sdLicense https://scigraph.springernature.com/explorer/license/
127 schema:sdPublisher N62e080324c46448cb5b1bc23f2fad7f9
128 schema:url https://doi.org/10.1007/s10067-014-2598-y
129 sgo:license sg:explorer/license/
130 sgo:sdDataset articles
131 rdf:type schema:ScholarlyArticle
132 N09fe4aecc61c4ba0ac87604dda8df794 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Serum Amyloid A Protein
134 rdf:type schema:DefinedTerm
135 N1432fcbd3c93411d9c1513541e427be6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Cytoskeletal Proteins
137 rdf:type schema:DefinedTerm
138 N1f38f75138934d6987bf65423700f94c schema:name dimensions_id
139 schema:value pub.1036607097
140 rdf:type schema:PropertyValue
141 N2452b5f62241486888aa16730c61a00f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Child
143 rdf:type schema:DefinedTerm
144 N30bb77e5cd344dbeb7ba5422fa93c1e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Blood Sedimentation
146 rdf:type schema:DefinedTerm
147 N36bfa23cf31b4e1db1f2ab77a916fc1c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Female
149 rdf:type schema:DefinedTerm
150 N44835f4928464b798c632038ab57a4be schema:volumeNumber 33
151 rdf:type schema:PublicationVolume
152 N47a9bc1a70c34659bbc1af2a2ad85673 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Humans
154 rdf:type schema:DefinedTerm
155 N516d3263a3ba4625856ecdd23eef9fee rdf:first sg:person.01237130624.98
156 rdf:rest Nb13e0dd9de95406e894732541131ccc5
157 N611cc40f86f449a393234934468d0385 schema:issueNumber 7
158 rdf:type schema:PublicationIssue
159 N62e080324c46448cb5b1bc23f2fad7f9 schema:name Springer Nature - SN SciGraph project
160 rdf:type schema:Organization
161 N6c6c194abd8d4f45a8a330edfd21d08e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Sensitivity and Specificity
163 rdf:type schema:DefinedTerm
164 N6f6cde9f3bb64ca592a79f938869b6b6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Double-Blind Method
166 rdf:type schema:DefinedTerm
167 N773956a9465048328d3debcc5aa2f57b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name C-Reactive Protein
169 rdf:type schema:DefinedTerm
170 N7ae58cc4217e41c396649193d8502eb8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Reproducibility of Results
172 rdf:type schema:DefinedTerm
173 N8611e88534e5463091069295fe64d075 rdf:first sg:person.01010215417.08
174 rdf:rest Na4cd24dcf021494da3becb8b6ff918ef
175 N9c1bde589d9c45f6a73a29f3663a43cf rdf:first sg:person.0755162262.20
176 rdf:rest Necd383cea59d4488bd43462f9859a2b4
177 N9df8fb72643d47f5aedc6eff7f7b3e17 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Tubulin Modulators
179 rdf:type schema:DefinedTerm
180 Na4cd24dcf021494da3becb8b6ff918ef rdf:first sg:person.01011617323.67
181 rdf:rest N9c1bde589d9c45f6a73a29f3663a43cf
182 Na6ed41d900e4410eacee370eb460e2db rdf:first sg:person.0712577637.37
183 rdf:rest N516d3263a3ba4625856ecdd23eef9fee
184 Nacd014ec9f7c47318e4018344d249425 schema:name pubmed_id
185 schema:value 24740462
186 rdf:type schema:PropertyValue
187 Nb13e0dd9de95406e894732541131ccc5 rdf:first sg:person.01141766457.76
188 rdf:rest rdf:nil
189 Nb200df1b232445aeb06a63e2f33c0f77 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Time Factors
191 rdf:type schema:DefinedTerm
192 Nb92c5fcf342148d982424ab4674f9214 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Child, Preschool
194 rdf:type schema:DefinedTerm
195 Nbdaf50792c174fa6bcac61c6d26666b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Familial Mediterranean Fever
197 rdf:type schema:DefinedTerm
198 Nc13db71f067b45adb1d616e39b4ad47d schema:name doi
199 schema:value 10.1007/s10067-014-2598-y
200 rdf:type schema:PropertyValue
201 Nda0bf2fa30684273bfc426b4e44aacbe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
202 schema:name Male
203 rdf:type schema:DefinedTerm
204 Ne095f855103d4a629424ef220c0a4ac0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
205 schema:name Cross-Over Studies
206 rdf:type schema:DefinedTerm
207 Necd383cea59d4488bd43462f9859a2b4 rdf:first sg:person.0741617600.62
208 rdf:rest Na6ed41d900e4410eacee370eb460e2db
209 Nef100bebac6d4af79dbfc0bb35ea4726 rdf:first sg:person.01146512213.34
210 rdf:rest N8611e88534e5463091069295fe64d075
211 Nf4185d1bf1b14348ac1c51155286d1b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
212 schema:name DNA Mutational Analysis
213 rdf:type schema:DefinedTerm
214 Nf9e0f4d9e8b84ea19fab2d36a08c1b9b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
215 schema:name Colchicine
216 rdf:type schema:DefinedTerm
217 Nfca43a4e39334102a750ff50faf71761 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
218 schema:name Pyrin
219 rdf:type schema:DefinedTerm
220 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
221 schema:name Medical and Health Sciences
222 rdf:type schema:DefinedTerm
223 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
224 schema:name Cardiorespiratory Medicine and Haematology
225 rdf:type schema:DefinedTerm
226 sg:journal.1093299 schema:issn 0770-3198
227 1434-9949
228 schema:name Clinical Rheumatology
229 schema:publisher Springer Nature
230 rdf:type schema:Periodical
231 sg:person.01010215417.08 schema:affiliation grid-institutes:grid.14442.37
232 schema:familyName Bilginer
233 schema:givenName Yelda
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010215417.08
235 rdf:type schema:Person
236 sg:person.01011617323.67 schema:affiliation grid-institutes:grid.14442.37
237 schema:familyName Gülhan
238 schema:givenName Bora
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01011617323.67
240 rdf:type schema:Person
241 sg:person.01141766457.76 schema:affiliation grid-institutes:grid.14442.37
242 schema:familyName Ozen
243 schema:givenName Seza
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01141766457.76
245 rdf:type schema:Person
246 sg:person.01146512213.34 schema:affiliation grid-institutes:grid.14442.37
247 schema:familyName Ozaltin
248 schema:givenName Fatih
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01146512213.34
250 rdf:type schema:Person
251 sg:person.01237130624.98 schema:affiliation grid-institutes:grid.14442.37
252 schema:familyName Yılmaz
253 schema:givenName Engin
254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01237130624.98
255 rdf:type schema:Person
256 sg:person.0712577637.37 schema:affiliation grid-institutes:grid.14442.37
257 schema:familyName Hayran
258 schema:givenName Mutlu
259 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0712577637.37
260 rdf:type schema:Person
261 sg:person.0741617600.62 schema:affiliation grid-institutes:None
262 schema:familyName Erdogan
263 schema:givenName Ozlem
264 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741617600.62
265 rdf:type schema:Person
266 sg:person.0755162262.20 schema:affiliation grid-institutes:grid.14442.37
267 schema:familyName Bajin
268 schema:givenName Inci
269 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755162262.20
270 rdf:type schema:Person
271 sg:pub.10.1038/nri3261 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029201311
272 https://doi.org/10.1038/nri3261
273 rdf:type schema:CreativeWork
274 sg:pub.10.1038/nrrheum.2010.181 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011009840
275 https://doi.org/10.1038/nrrheum.2010.181
276 rdf:type schema:CreativeWork
277 sg:pub.10.1038/sj.ejhg.5200446 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052810936
278 https://doi.org/10.1038/sj.ejhg.5200446
279 rdf:type schema:CreativeWork
280 sg:pub.10.1038/sj.ejhg.5200674 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001982403
281 https://doi.org/10.1038/sj.ejhg.5200674
282 rdf:type schema:CreativeWork
283 grid-institutes:None schema:alternateName Sami Ulus Children’s Hospital, Ankara, Turkey
284 schema:name Sami Ulus Children’s Hospital, Ankara, Turkey
285 rdf:type schema:Organization
286 grid-institutes:grid.14442.37 schema:alternateName Department of Medical Biology, Hacettepe University Faculty of Medicine, Ankara, Turkey
287 Department of Preventive Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey
288 Departments of Pediatric Nephrology and Rheumatology, Hacettepe University Faculty of Medicine, 06100, Ankara, Sihhiye, Turkey
289 schema:name Department of Medical Biology, Hacettepe University Faculty of Medicine, Ankara, Turkey
290 Department of Preventive Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey
291 Departments of Pediatric Nephrology and Rheumatology, Hacettepe University Faculty of Medicine, 06100, Ankara, Sihhiye, Turkey
292 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...